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We examined the eﬀect of a 9-week diet and physical activity intervention provided in the workplace by a group education session
where personal dietary and physical activity goals were proposed. Measurements of anthropometry, fasting blood lipids, glucose
and insulin, assays for antioxidant activity (AOA) and questionnaires were completed at 0, 3, 6, 9, and 12 weeks in 50 healthy
workers (50% male, mean age 46y). Followup measurements in 39 (56% male) were possible at 52 weeks. At week 3 a group
dietary and physical activity “motivational seminar” was held. At week 6, half the group were supplied daily kiwifruit for 3 weeks
with cross over at week 9 until week 12. Compared to baseline, lipid, glucose, insulin and AOA measurements were improved at
12 and 52 weeks. Body measurements did not change. Group diet and physical activity advice reinforced over 9 weeks is associated
with a sustained improvement in cardiovascular risk factors at 52 weeks.
Copyright © 2009 Elaine C. Rush et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. Introduction
Diet and physical activity are major modifiable factors [1]
that help prevent or delay lifestyle-related chronic diseases
such as cardiovascular disease (CVD), hypertension, type
2 diabetes mellitus and cancer. The prevalence of “chronic
lifestyle disease” rapidly increases as a population ages, yet
it is calculated that at least 80% of CVD, stroke and type
2 diabetes, and 40% of cancer could be avoided through
healthy diet, regular physical activity, and not using tobacco
[2, 3]. The Global Burden of Disease Study [4] ranked 25
major risk factors for death and disability in the world. High
blood pressure was ranked third, obesity fourth, high blood
cholesterol seventh, low fruit and vegetable intake twelfth,
and physical inactivity ranked fourteenth [5]. Research
supports the claim that a diet high in fruit, vegetables,
whole grains, and low in saturated fat, sugar, and salt with
increased physical activity can reduce the risk of CVD and
generally improve health, blood glucose concentrations, and
lipid profile [6].
The pathophysiology associated with the development
of each lifestyle disease diﬀers and mechanisms by which
diet and physical activity reduce risk are complex and
related to societal and environmental factors[7]. At a
physiological level beta cell and endothelial dysfunction
are related to oxidative stress induced by the reactive
species (RS) produced by the metabolic processes of the
body [8, 9]. An oxidant-antioxidant balance [6] may be
improved by consuming a healthier diet including a variety
of fruits, vegetables, whole grains, and oily fish because
they contain a complex mixture of natural antioxidant
micronutrients that are associated with the long term
outcome of disease prevention [9]. One readily available
fruit that has a high level of antioxidants is kiwifruit
which has been shown to protect against oxidative DNA
damage [10]. We have previously shown that the provi-
sion of kiwifruit for three weeks improved laxation [11].
Further investigation of the short-term eﬀects of kiwifruit
on oxidant status and risk factors for chronic disease is
warranted.
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Figure 1: Study design.
Increased physical activity and dietary change at the
individual level often requires intensive one-to-one advice,
and the changes may reverse after the intervention stops [12].
The workplace is a natural setting to work with groups, where
collegial and social support for behavioural change can be
provided and for putting in place sustainable environmental
change [13]. The workplace setting allows provision and
distribution of a “prescribed” fruit.
The overall purpose of this study was to assess, after a
nine-week group intervention with follow-up at one year,
the eﬀects of relatively small integrated lifestyle changes
such as a healthier diet (more fruit and vegetables, whole
grains and oily fish) and increased physical activity on risk
factors including antioxidant status. We hypothesised that a
workplace group diet and activity intervention would reduce
plasma glucose and insulin, improve fasting lipid profile and
increase antioxidant activity (AOA). A second hypothesis was
that the addition of kiwifruit to the diet for three weeks
would improve plasma glucose, lipid concentrations, and
AOA.
2. Methods
This study was a 12 weeks longitudinal group intervention
study with a followup after 52 weeks (Figure 1). Staﬀ from
the Auckland University of Technology aged 30 years or more
were recruited by advertisement and personal contact. It
was expected that in this age range, risk factors for lifestyle
diseases would be likely to be found. Exclusion criteria were
type 2 diabetes mellitus, pregnancy, known hypertension, or
use of medication for elevated cholesterol. Fifty (25 male, 25
female) healthy subjects, mean age 46 years, completed all
measurements at 0, 3, 6, 9, and 12 weeks. Thirty eight were
self-identified as New Zealand European, 5 as British, 3 as
Maori, 1 as Tongan, 2 as Samoan, and 1 as Indian. Thirty-
nine subjects presented for a sixth set of measurements at 52
weeks. Of the 11 who did not present, 3 were pregnant, 1 had
left the place of employment, 2 were on leave, 2 declined to
participate and 3 agreed to participate but did not present.
Ethical approval was granted by the AUT ethics committee,
Ref 02/08.
Food frequency and physical activity questionnaires,
designed to ask questions about current practice around the
dietary and physical activity goals of the intervention, were
completed at each time point. Measurements of anthropom-
etry (skinfolds, waist girths, weight and height following
standard techniques), blood pressure and fasting plasma
lipids, glucose, insulin and antioxidant status were made at
each time point. DNA fragility was measured by comet assay
in a subgroup, and these results have been reported elsewhere
[14].
Fasting venous blood samples were collected by a trained
phlebotomist. Fresh plasma was analyzed for glucose, lipids
and insulin. Samples for antioxidant measurement were put
on ice in EDTA tubes and centrifuged within 10 minutes
at 2500 rpm for 7 minutes. Plasma was stored at −85◦C
until analysis. Glucose was measured by the Roche-Hitachi
glucose oxidase method, insulin by the Abbot IMx Insulin
assay method, total and LDL cholesterol by the standard
Roche-Hitachi methodology, and HDL cholesterol by direct
assay. These measurements were made at the Diagnostic
Medlab (Ltd) laboratory which is IANZ accredited. The
homeostasis model assessment (HOMA) [15] calculation
using a DOS programme supplied by Jonathan Levy was
utilized to measure beta-cell function (HOMA-B%) and
insulin sensitivity (HOMA-S%). The ferric reducing ability
of plasma (FRAP) assay [16] was utilized to measure soluble
antioxidants as plasma AOA. Changes in plasma malondi-
aldehyde (MDA), as a marker of lipid peroxidation (LP) were
measured as thiobarbituric acid reactive substances (TBARS)
[17].
Between measurements at weeks 0 and 3, the volunteers
were allowed to follow their usual food and activity pattern.
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The three week run-in period was to measure the eﬀect
of participation in an intervention study prior to the
active intervention [18]. After the 3 weeks measurements
the group gathered together for motivational talk on diet
and exercise, and were provided with tailored written
material and pedometers to increase motivation. Details
of the diet and physical activity goals and advice have
been published as part of a thesis [19]. In summary, the
tailored written food based dietary advice recommended
daily numbers of standard servings of fruit and vegetables,
low fat dairy and milk products, lean meats and cereals
and wholegrains adjusted according to body size, sex and
need to lose weight. The number of servings of each
food group was balanced over 3 meals and 3 snacks so
that the recommended diet was 50%–60% energy from
carbohydrates, 15–18% energy from protein and 24%–27%
energy from fat. Choices of foods with less sugar, saturated
fat and salt were recommended with advice emphasising an
increase in dietary fibre by increasing fruit, vegetables and
whole grains and an increase in omega-3 fatty acid mainly
from consumption of oily fish. Two in-house booklets were
distributed. One booklet contained partially individualized
dietary information, hints for improving diet and physical
activity, and goal sheets to help motivate participants.
The other booklet included recipes to help implement
dietary changes, for example, lower fat, the use of less-used
ingredients like legumes, beans, and oily fish. The activity
advice was based on regular and gradual increases in physical
activities, which are easy to maintain and build for a long
term.
Pedometers (Digiwalker SW-700) were issued to the
participants to help motivate them to increase their physical
activity. It was recommended that they aim to do a minimum
of 10 000 steps per day. Participants were encouraged
to maintain the recommended diet and physical activity
improvements throughout the study and “for the rest of their
lives!”
The third set of measurements was made at the end
of week 6. After these measurements the subjects were
randomly divided into two groups. The first group (A) were
provided with kiwifruit at a daily dose of one kiwifruit/30 kg
body weight for three weeks while the second group (B) were
asked to abstain from consumption of kiwifruit. This dose
was chosen because in our study of the laxative eﬀects of
kiwifruit [11] significant changes in laxation and therefore
presumably eﬀects of increased fibre were seen in 42 elderly
people after 3 weeks of treatment following this regime.
Following measurement at week 9, group A abstained from
kiwifruit while Group B added the kiwifruit to their diet
and the measurements were repeated at week 12. At weeks
9 and 12 participants were asked to provide an indication
of the goals that they had set and if they had accomplished
them. After completion of these measurements, participants
were given a copy of their results, a group summary which
showed good outcomes, and encouragement to continue.
After 52 weeks, with only three-monthly emails as updates
about diet and activity, they were invited to have the
measurements repeated and complete the same question-
naires.
3. Statistical Analysis
Two-way repeated measures ANOVA and paired t-tests were
used to assess the eﬀect of diet and activity advice on the
biochemical markers within individuals before, during and
after the intervention. Baseline for the diet and activity
intervention was week 0, that is, before the run-in period
where participants had some knowledge of who was in the
trial. Analysis of the eﬀects of kiwifruit was performed using
the methods of Hills and Armitage [20] for crossover trials
to examine treatment, period and interaction eﬀects. Data
normality was tested with the Kolmogorov-Smirnov test.
Statistical analysis was carried out using SPSS v.13 (SPSS
Inc, Chicago, IL). Statistical significance was set at P < .05.
Results are expressed as mean ± standard deviation (SD)
unless stated otherwise.
4. Results
Most participants were self-reported “health conscious”
individuals and were aware of the importance of healthy
diet and physical activity according to their answers to
the food frequency and physical activity questionnaires at
the beginning of the study. However, from the baseline
measurements made at weeks 0 and 3, a variety of biological
risk factors were identified. Seventy-four percent of the
participants were classified as being overweight or obese
using BMI cut-oﬀ values [21] and 11 women and 6 men
had waist measurements [22] that indicated that their
abdominal fat stores were placing them at risk of CVD and
type 2 diabetes. Seventy percent of subjects had elevated
total plasma cholesterol (>5.0 mmol/L) and LDL cholesterol
(>3.0 mmol/L) and 40% had a total to HDL cholesterol ratio
over 4.5 mmol/L. Fifteen percent of participants had a high
plasma insulin level (>50 pmol/L). High blood pressures
(systolic >140 mmHg and/or diastolic >90 mmHg) were
found in five participants. No changes in anthropometry
or blood pressure were seen over the 12-week study period
(Table 1).
Compared to baseline (week 0), total cholesterol, LDL
cholesterol, and total to HDL cholesterol ratio were lower at
the end of the 12-week study period (Table 2). Mean total
cholesterol decreased by 0.4 mmol/L over this period (P <
.0001) and LDL cholesterol by 0.4 mmol/L (P = .001) but
HDL cholesterol did not change (P = .22). Total to HDL
cholesterol ratio decreased 0.3 (P < .0001), a change of 8%.
In females compared with males, over the 12-week study
period, HDL cholesterol was higher (P < .001) and total to
HDL cholesterol ratio lower (P = .002, data not shown). At
week 12, HDL cholesterol was 1.37± 0.24 mmol/L in men
and 1.58± 0.34 mmol/L in women (P = .01) while total to
HDL cholesterol ratio was 4.08± 0.92 in men and 3.41± 0.88
in women (P = .01).
Risk factors for type 2 diabetes, viz, plasma insulin and
glucose, beta-cell function (measured as HOMA B%), and
insulin sensitivity (measured as HOMA S%) remained stable
over the first 12 weeks of diet and activity intervention
(Table 2). During the 12-week period, mean plasma AOA
increased at each measurement point but the average increase
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Table 1: Anthropometry for 50 subjects over 12 weeks.
Week 0 Week 3 Week 6 Week 9 Week 12
P∗
Mean ±SD Mean ±SD Mean ±SD Mean ±SD Mean ±SD
Weight, kg 80.0 ±13.2 80.1 ±13.2 80.0 ±13.0 80.1 ±12.9 80.0 ±13.1 .98
BMI, kg/m2 27.0 ±4.6 27.1 ±4.6 27.0 ±4.5 27.1 ±4.6 27.1 ±4.5 .99
Waist, cm 91.2 ±11.4 90.8 ±11.4 90.5 ±11.3 91.4 ±11.0 91.8 ±10.8 .17
Systolic, mmHg 117 ±14 120 ±12 117 ±12 118 ±12 117 ±14 .55
Diastolic, mmHg 77 8 76 ±9 75 ±8 76 ±10 76 ±10 .51
∗P value for changes over time by repeated measures ANOVA with sex as fixed eﬀect (time × sex and sex eﬀects were nonsignificant for all variables). BMI,
body mass index.
Table 2: Blood biochemistry for 50 subjects over 12 weeks.
Week 0 Week 3 Week 6 Week 9 Week 12 †P
Mean ±SD Mean ±SD Mean ±SD Mean ±SD Mean ±SD
Total cholesterol, mmol/L 5.7 ±1.1 5.5 ±1.0∗ 5.4 ±1.0∗ 5.5 ±1.0∗ 5.3 ±1.0∗ <.001
LDL cholesterol, mmol/L 3.6 ±1.0 3.5 ±0.9 3.4 ±1.0∗ 3.4 ±0.9∗ 3.3 ±0.9∗ <.001
HDL cholesterol, mmol/L 1.47 ±0.31 1.40 ±0.30 1.37 ±0.30 1.46 ±0.32 1.47 ±0.31 ‡.19
Total cholesterol /HDL 4.03 ±1.11 4.08 ±1.12 4.09 ±1.11 4.00 ±1.08 3.74 ±0.95∗ ‡ < .001
Triglyceride, mmol/L 1.3 ±0.7 1.3 ±0.7 1.3 ±0.7 1.5 ±0.9 1.2 ±0.6 .59
Glucose, mmol/L 5.2 ±0.5 5.1 ±0.5 5.0 ±0.5 5.0 ±0.5 5.1 ±0.5 .16
Insulin, pmol/L 56 ±27 57 ±29 53 ±26 57 ±28 54 ±30 .49
HOMA B% 90 ±28 93 ±27 91 ±27 97 ±27 89 ±27 .79
HOMA S% 121 ±55 115 ±66 122 ±53 119 ±54 120 ±45 .12
AOA (μmol/L) 1221 ±423 1260 ±425 1293 ±479 1338 ±451∗ 1336 ±514 .03
TBAR (mmol/L) 1.79 ±0.25 1.77 ±0.25 1.78 ±0.23 1.79 ±0.25 1.80 ±0.25 ‡.37
∗
Significantly diﬀerent to week 0; †P value for changes over time by repeated measures ANOVA with sex as fixed eﬀect (time × sex eﬀects were nonsignificant
for all variables); ‡women significantly diﬀerent to men, HOMA homeostatic model assessment, AOA antioxidant activity, TBAR thiobarbituric acid reactive
substances.
of 116 mmol/L in plasma AOA between week 0 and week
12 (from 1220± 423 to 1336± 514 μmol/L) did not reach
statistical significance, (P = .069).
Because a smaller change in antioxidant status was
expected in those who entered the study with a high antiox-
idant status, the cohort was divided into those with AOA <
1200 μmol/L (n = 26) at baseline and AOA > 1200 μmol/L.
A significant increase (200 μmol/L, from 936± 182 to
1136± 440 μmol/L, P = .011) was seen in the participants
with lower AOA at baseline and no change observed in those
with high AOA (1542± 80 to 1561± 106 μmol/L, P = .85).
Lipid peroxidation did not change between week 0 and week
12.
Analysis of the kiwifruit cross-over trial showed no
significant eﬀect of kiwifruit consumption on lipid profile or
glucose and insulin measures, and therefore is not reported
in detail. Compliance for kiwifruit consumption was con-
firmed verbally when the kiwifruit was delivered each week
but also confirmed by the food frequency questionnaire.
In the 39 subjects (22 M, 17 F) who were measured
at 52 weeks, there were no changes in anthropometric
data but systolic blood pressure increased from baseline
(Table 3). The 4 mmHg increase is probably not clinically
meaningful. Favourable blood lipid changes seen over the 12
weeks persisted at 52 weeks (Figure 2 and Table 4); glucose
and insulin decreased significantly and insulin sensitivity
increased. Insulin in males was maintained (week 0, 56± 28;
week 52, 55± 29 pmol/L, P = .87) but decreased in females
(week 0, 66 ± 34; week 52, 49± 27 pmol/L, P < .0001) and
insulin sensitivity increased in females only (P < .001). AOA
increased, particularly in those who had an initial level less
than 1200 μmol/L.
An increase in plasma AOA was maintained by 16 (73%)
of the 22 low AOA participants measured at one year (P =
.01). Lipid peroxidation increased a little at week 52.
Assessed by food frequency questionnaire over the 52-
week period, the proportion of participants consuming fruit
at a rate of 2 or more portions per day increased from 47% to
62% and for oily fish 3 times a week from 14% to 42%. The
number of participants reporting that they were undertaking
any moderate or vigorous activity during the week increased
from 36% to 56%. Associations of change in frequency of
consumption of fruits, vegetables, whole grain and time
spent in physical activity with changes in metabolic risk were
explored but the only significant relationship was between
an increase in the frequency of intake of whole grains and a
reduction in total cholesterol (r = −0.323,P = .02). From
week 0 to week 52 there was a significant increase in kiwifruit
consumption (Wilcoxon signed rank test, P < .001) with
22 increasing and 3 reducing their consumption. Kiwifruit
consumption from weeks 6–9 was not a valid comparison as
it was supplied to only half the group.
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Table 3: Anthropometry at baseline (week 0) and follow-up (week 52) for 39 subjects.
Week 0 †P †P
Mean ±SD Mean ±SD
Weight, kg 80.0 ±14.1 79.9 ±14.4 .98
BMI, kg/m2 27.0 ±4.6 27.0 ±4.8 .96
Waist, cm 90.8 ±11.5 91.0 ±10.8 ‡.69
Systolic, mmHg 118 ±14 122 ±13 <.007
Diastolic, mmHg 77 ±8 77 ±9 .75
†
P value for changes over time by repeated measures ANOVA with sex as fixed eﬀect (time × sex eﬀects were nonsignificant for all variables)
‡women significantly diﬀerent to men.
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Figure 2: Measurements of total cholesterol (open diamond), LDL cholesterol (closed circle), the ratio of total to HDL cholesterol (open
circle) and HDL cholesterol (closed triangle) over 52 weeks in 39 volunteers. Data are mean ± SEM.
5. Discussion
The overall question asked in this study was “will group
advice and support to increase daily fruit, vegetable, whole
grain and oily fish intake and increase physical activities
improve glucose and lipid levels and antioxidant activity
in the blood and therefore, decrease the risk of lifestyle
diseases?”
The answer is yes. This study demonstrated that a group
work-based dietary and activity intervention was associated
with reduction of some biomarkers of risk for lifestyle
disease.
A reduction in total cholesterol levels of 0.6 mmol/L is
associated with a 24% reduction in death from ischemic
heart diseases [23]. The improvement in lipid profile was
one of the sustained changes in this study. Total cholesterol
was reduced from 5.7± 1.1 to a mean 5.3± 1.0 mmol/L
over the 12 weeks and maintained at that level at 52
weeks. One third of the participants in this study at one
year decreased their total plasma cholesterol by more than
0.6 mmol/L, maintained their HDL levels and sustainably
and significantly improved their total cholesterol/HDL ratio.
This intervention also resulted in an overall significant
decrease in plasma glucose, and an increase in insulin
sensitivity, which must be considered an encouraging trend.
Most studies looking at reduction of type 2 diabetes risks
have looked at changes that are aiming to improve the
metabolic control of people with type 2 diabetes or who
already have impaired glucose tolerance (IGT) [24]. Given
the huge increase in the prevalence of type 2 diabetes and
the expected increase in incidence over the next decade, it
is important to implement lifestyle changes in those who
appear to be normoglycemic as well as in those who have
IGT.
The changes in the blood biochemistry were not accom-
panied by changes in weight or waist measurement. It was
not one of the aims of this study to reduce weight or body
fat substantially. Anthropometric changes or prevention of
weight gain take time, particularly when the objective is for
the changes to be small and sustainable, rather than to make a
substantial impact on body composition that could possibly
compromise sustainability.
The changes in diet and physical activities significantly
increased the plasma soluble antioxidant activity during the
12-week period, and therefore potentially decreased the level
of oxidative damage. As was expected, antioxidant status
improved more significantly in subjects with relatively low
initial AOA and maintained that elevation out to one year.
6 Journal of Environmental and Public Health
Table 4: Blood biochemistry at baseline (week 0) and follow-up (week 52) for 39 subjects.
Week 0 Week 52 †P
Mean ±SD Mean ±SD time sex time × sex
Total cholesterol, mmol/L 5.6 ±1.1 5.3 ±1.0 <.001 .20 .82
LDL cholesterol, mmol/L 3.6 ±1.0 3.2 ±0.9 <.001 .07 .91
HDL cholesterol, mmol/L 1.44 ±0.34 1.47 ±0.31 .26 .06 .50
Total cholesterol /HDL 4.10 ±1.11 3.76 ±0.97 <.001 .001 .29
Triglyceride, mmol/L 1.2 ±0.5 1.3 ±0.5 .68 .05 .06
Glucose, mmol/L 5.2 ±0.4 5.0 ±0.4 .01 .39 .59
Insulin, pmol/L 59 ±29 50 ±26 .005 .52 .023
HOMA B% 93 ±30 90 ±27 .25 .28 .09
HOMA S% 110 ±48 128 ±51 .02 .76 .05
AOA (μmol/L) 1213 ±429 1320 ±372 .03 .36 .81
TBAR (mmol/L) 1.79 ±0.24 1.83 ±0.25 .06 .08 .87
†
P values for repeated measures ANOVA with sex as fixed eﬀect: HOMA homeostatic model assessment, AOA antioxidant activity, TBAR thiobarbituric acid
reactive substances.
Some fruits or vegetables are particularly rich in antiox-
idant vitamins and phytochemicals, and it is reasonable
to suggest that there will be significant health benefits
associated with regular consumption of that particular fruit
or vegetable. In this regard the eﬀect of kiwifruit on markers
of oxidative stress and blood biochemistry was tested as a
part of this intervention study, in a cross over trial design.
Kiwifruit contains very significant amounts of antioxidants
such as ascorbic acid, folate and flavonoids [25]. There are
on average 1.6 grams of dietary fiber in one kiwifruit. The
antioxidant properties of this fruit have been demonstrated
to protect against oxidative DNA damage [10] and to
stimulate DNA repair [14, 26] by promoting DNA repair
enzymes. Flavonoids present in kiwifruit may also have
antioxidant as well as anti-thrombotic properties. It has
recently been reported that consuming 2 or 3 kiwifruit per
day for 28 days reduces platelet aggregation and decreases
plasma triglyceride levels [27]. Both these responses are
favourable for reduction of risk factors for CVD. However,
in the present study, the eﬀect of three weeks treatment with
kiwifruit on markers of oxidative stress was rather more
modest than anticipated, and did not significantly aﬀect
blood biochemistry over 3 weeks. Specifically, the 3-week
daily kiwifruit consumption (2-3 kiwifruit per day) resulted
in a significant increase in plasma AOA, as measured by
FRAP, in female but not in male participants, but did not
change markers of LP measured as plasma MDA in either sex.
This study was limited by the self-selection of par-
ticipants, its relatively small sample size and incomplete
follow-up of all participants. The identification of responders
and non-responders to changes in antioxidant status and
apparently a better response (or compliance) from women
needs to be studied further. Many of the changes made
by the participants of this study were not measurable, but
most participants personally described changes in attitude,
awareness and motivation. This study has shown that group
advice in the workplace for changes in diet and physical
activity is associated with favourable changes in blood
biochemistry even without accompanying changes in waist
and weight. Furthermore, the biochemical changes and
presumably changed behaviour persisted over 52 weeks. The
next step is to change the workplace environment to support
the healthier food choices and opportunities for physical
activity so that the healthy choice becomes the easier choice.
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